Mortality Rate in Hospitalized Pediatric Patients with COVID-19 Infection in Iran: A Systematic Review and Meta-Analysis

Document Type : Systematic Review

Authors

1 Department of Pediatrics, Islamic Azad University of Yazd, Yazd, Iran

2 Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

5 Department of Medical Laboratory Sciences, School of Paramedical Science, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: There is little data on the mortality rate and severity of COVID-19 infection among pediatrics. This knowledge is particularly significant because pneumonia is the main underlying cause of death in children worldwide. This systematic review and meta-analysis aims to evaluate the mortality rate of COVID-19 in the pediatric population in Iran.
Methods: A systematic review and meta-analysis of the publications was conducted based on the PRISMA guidelines to search for COVID-19 child mortality. PubMed, Google Scholar, Embase, Medline databases, and Persian database were searched for publications on pediatric COVID-19 infections published in Iran with a focus on mortality in children with COVID -19 infection in Iran between January 1st to April 30th, 2021. Articles representing at least one Pediatric with and without comorbidities, COVID-19 infection, and informed outcomes were examined.
Results: Eight studies including three case series, and five retrospective cross-sectional studies altogether representing a total of 238 pediatric patients with COVID-19 were included in this meta-analysis. Of this population, 14 patients had died. In this study, the mean age of the study sample was 6.7 years. The mortality rate among children hospitalized with COVID-19 was 9% (95% CI 0.055-0.146). Also, children with comorbidities had a higher risk of COVID-19 related mortality.
Conclusion: Unlike adults, most infected children are asymptomatic and are not usually hospitalized. Children with underlying conditions are at increased risk of severe COVID-19 related mortality than children without underlying illness. More attention should be paid to children with comorbidities and children of young age.

Keywords


  1. Bahrami R, Ekraminasab S, Asadian F. A survey on cardiac complications of COVID-19 in infants. World J Peri & Neonatol 2021; 4(1): 50-9.
    2. Javaheri A, Noorishadkam M, Mazaheri M, Dadbinpour A, Dastgheib SA, Bahrami R, et al. Current state of knowledge about transplacental transmission of SARS-CoV-2 infection. World J Peri & Neonatol 2021; 3(2): 50-5.
    3. Baghalsafa F, Neamatzadeh H, Ekraminasab S. Death of a 3 month-old infected infant with dilated cardiomyopathy after COVID-19 infection: A case report. World J Peri & Neonatol 2021; 4(1): 60-4.
    4. Noorishadkam M, Lookzadeh MH, Mazaheri M, Mirjalili SR, Bahrami R, Asadian F, et al. Coronavirus disease 2019 (COVID-19) and late pregnancy loss in infected pregnant women: A mini review. World J Peri & Neonatol 2020; 2(2): 67-70.
    5. Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol 2020; 41(5): 102573.
    6. Bahrami R, Neamatzadeh H, Akbarian E. COVID-19 and renal complications in neonates and pediatrics. World J Peri & Neonatol 2020; 3(2): 48-9.
    7. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. JAMA Pediatr 2020; 174(9): 882-9.
    8. Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. International Severe COVID-19 infection and pediatric comorbidities : A systematic review and meta-analysis. Int J Infect Dis 2021; 103: 246-56.
    9. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress 2020; 4(4): 66-75.
    10. Soltani J, Sedighi I, Shalchi Z, Sami G, Moradveisi B, Nahidi S. Pediatric coronavirus disease 2019 (COVID-19): An insight from west of Iran. North Clin Istanb 2020; 7(3): 284-91.
    11. Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R, et al. Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience. J Med Virol 2021; 93(1): 424-33.
    12. Mamishi S, Movahedi Z, Mohammadi M, Ziaee V, Khodabandeh M, Abdolsalehi MR, et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children : a first report from Iran. Epidemiol Infect 2020; 148: e196.
    13. Shahbaznejad L, Rouhanizadeh H, Navaeifar MR, Hosseinzadeh F, Movahedi FS, Rezai MS. Clinical characteristics and outcomes of COVID-19 in children in Northern Iran. Int J Pediatr 2021; 2021: 5558287.
    14. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-62.
    15. Caussy C, Wallet F, Laville M, Disse E. Obesity is associated with severe forms of COVID-19. Obesity (Silver Spring) 2020; 28(7): 1175.
    16. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55(5): 2000547.
    17. Mamishi S, Heydari H, Aziz-Ahari A, Shokrollahi MR, Pourakbari B, Mahmoudi S, et al. Novel coronavirus disease 2019 (COVID-19) outbreak in children in Iran: Atypical CT manifestations and mortality risk of severe COVID-19 infection. J Microbiol Immunol Infect 2021; 54(5): 839-44.
    18. Eghbali A, Shokrollahi S, Mahdavi NS, Mahdavi SA, Dabbagh A. COVID-19 in pediatric patients: A case series. J Cell Mol Anesth 2020; 5(1): 3-5.
    19. Esmaeeli H, Ghaderian M, Sayadpour Zanjani K, Ghalibafan SF, Mahdizadeh M, Aelami MH. COVID-19 in children with congenital
    heart diseases: A multicenter case series from Iran. Case Rep Pediatr 2021; 2021: 6690695.
    20. Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, Navaeifar MR, Enayati AA, Manafi A, et al. COVID-19 infection in Iranian children: A case series of 9 patients. J Pediatr Rev 2020; 8(2): 139-44.
    21. Mehrvar A, Qaddoumi I, Tashvighi M, Naderi A, Mousakhani H, Alasvand R, et al. Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran. Semin Oncol 2021; 48(4-6): 295-303.
    22. Smith C, Odd D, Harwood R, Ward J, Linney M, Clark M, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med 2022; 28(1): 185-92.
    23. Karimi A, Rafiei Tabatabaei S, Rajabnejad M, Pourmoghaddas Z, Rahimi H, Armin S, et al. An algorithmic approach to diagnosis and treatment of coronavirus disease 2019 (COVID-19) in children: Iranian expert‟s consensus statement. Arch Pediatr Infect Dis 2020; 8(2): e102400.
    24. Bhopal SS, Bagaria J, Olabi B, Bhopal R. COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality. Public Health 2020; 188: 32-4.
    25. Pediatric AA of. Children and COVID-19: State data report 4 February 2021. Child Hosp Assoc 2021; 1-26.
    26. Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine 2020; 26: 100527.
    27. Pudjiadi AH, Putri ND, Sjakti HA, Yanuarso PB, Gunardi H, Roeslani RD, et al. Pediatric COVID-19: Report from indonesian pediatric society data registry. Front Pediatr 2021; 9: 716898.
    28. Dewi R, Kaswandani N, Karyanti MR, Setyanto DB, Pudjiadi AH, Hendarto A, et al. Mortality in children with positive SARS-CoV-2 polymerase chain reaction test : Lessons learned from a tertiary referral hospital in Indonesia. Int J Infect Dis 2021; 107: 78-85.                                                                                                              29. Lookzadeh MH, Ekraminasab S, Baghalsafa F. Outcome of a neonate born to a mother with COVID-19: A case report of vertical transmission. World J Peri & Neonatol 2022; 4(2): 124-9.
    30. Di Giorgio A, Nicastro E, Arnaboldi S, Montini O, Di Stasio F, D'Antiga L, et al. Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study. Clin Res Hepatol Gastroenterol 2021; 45(2): 101610.
    31. Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020; 371: m3731.
    32. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584(7821): 430-6.